Pulsenmore
Handheld Ultrasound Device
Company Overview
Snapshot
Founded in October 2014 by Elazar Sonnenschein, Pulsenmore operates with 51–200 employees. The company has raised a total of $110.8M across 5 funding rounds from 6 investors. In January 2026, Pulsenmore announced its shares would commence trading on Nasdaq, expanding its FDA-authorized home prenatal ultrasound devices in the U.S.
Business overview
Pulsenmore develops a universally accessible home ultrasound device for remote care, enabling patients to self-scan using a handheld ultrasound cradle connected to their smartphone. The technology facilitates remote clinical assessment by healthcare providers, particularly for at-home prenatal ultrasound to monitor fetal well-being. The company's solutions aim to enhance care availability, improve resource management, and increase patient satisfaction within the Health Tech & Life Sciences sector, specifically targeting medical devices, digital healthcare, and patient remote monitoring.
Strategic signal
In November 2025, Pulsenmore received FDA De Novo Marketing Authorization for its home-use prenatal ultrasound, marking a significant regulatory milestone for the company. This authorization is a strong signal to investors, validating the technology's safety and efficacy for the U.S. market and positioning Pulsenmore as a pioneer in remote prenatal care. This development is expected to drive substantial growth and market penetration in a key global healthcare market.
Log in to access full profile ›Company Intelligence Q&A
- What significant regulatory approval did Pulsenmore receive in the U.S.?
- In November 2025, Pulsenmore received FDA De Novo Marketing Authorization for its home-use prenatal ultrasound device, marking a new era for prenatal care in the U.S.
- What was a key strategic development for Pulsenmore in January 2026?
- In January 2026, Pulsenmore announced its shares would commence trading on Nasdaq, coinciding with the expansion of its FDA-authorized home prenatal ultrasound devices in the U.S.
- When did Pulsenmore expand its partnership with Clalit Health Services?
- In October 2024, Pulsenmore expanded its partnership with Clalit Health Services to deliver 25,000 home ultrasound devices for remote prenatal care.
- What new commercial engagement did Pulsenmore announce in February 2026?
- In February 2026, Pulsenmore announced its first commercial engagement with a leading U.S.-based medical center, building momentum in the U.S. market after FDA clearance.
- What leadership appointment did Pulsenmore make in June 2024?
- In June 2024, Pulsenmore appointed Len Farris as.